ERRATUM: 2018 recommendations for the management of community acquired pneumonia

doi:10.1590/s1806-37562018000000130errata2

J. bras. pneumol.

2019

DOI: 10.1590/s1806-37562018000000130errata2

|View full text |Cite

ERRATUM: 2018 recommendations for the management of community acquired pneumonia

Abstract: J Bras Pneumol. 2019;45(2):e20180130 Manuscript: 2018 recommendations for the management of community acquired pneumonia Publication: J Bras Pneumol. 44(5):405-423

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Modern approaches to pharmacotherapy of Community-Acquired Pneumonia

Gavrilova¹,

Bontsevich²,

Vovk³

et al. 2020

RRP

View full text Add to dashboard Cite

Introduction: The study presents current views on the pharmacotherapy of community-acquired pneumonia (CAP). This study also describes in general terms the current pharmacoepidemiological situation of the CAP in Russia and abroad, which can both help medical professionals make an informed choice when choosing a pharmacotherapy, and inspire them to follow-up research and observations. The aim of the study is to conduct an analysis of the available research on the pharmacotherapy of CAP in order to accelerate the accumulation and assimilation of knowledge in the field of this pathology. Materials and methods: The following databases of medical publications and electronic libraries were used to search for the relevant sources of information: PubMed, Medline, Google Scholar, Crossref, and eLIBRARY.RU. Results and discussion: The choice of a rational antimicrobial therapy (AMT) for CAP is of high relevance due to the widespread of the pathology. The article highlights modern approaches to the pharmacotherapy of CAP in adults, including a review of promising new drugs, and presents the main problematic issues related to the emergence of antibiotic resistance of pathogens, as well as methods to combat it. Conclusion: The analyzed and generalized results of the conducted research allow the authors to make a conclusion about the feasibility of a more detailed study and raising the level of awareness of medical professionals in this pathology.

show abstract

Modern approaches to pharmacotherapy of Community-Acquired Pneumonia

Gavrilova¹,

Bontsevich²,

Vovk³

et al. 2020

RRP

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

ERRATUM: 2018 recommendations for the management of community acquired pneumonia

Abstract: J Bras Pneumol. 2019;45(2):e20180130 Manuscript: 2018 recommendations for the management of community acquired pneumonia Publication: J Bras Pneumol. 44(5):405-423

Cited by 1 publication

References 0 publications

Modern approaches to pharmacotherapy of Community-Acquired Pneumonia

Modern approaches to pharmacotherapy of Community-Acquired Pneumonia

Contact Info

Product

Resources

About